By Ethan Covey
A medication-use evaluation of ceftolozane-tazobactam (Zerbaxa, Merck) and ceftazidime-avibactam (Avycaz, AbbVie) in a Florida Veterans Affairs hospital found a significant reduction in susceptibility for Pseudomonas aeruginosa over time.
The findings demonstrate the importance of evaluating antibiotic use patterns in hospitals, and how such data can allow for better informed decisions regarding antibiotic stewardship programs, according to a presentation at the MAD-ID (Making a